Cargando…
Cellular prognostic markers in hepatitis-related hepatocellular carcinoma
Hepatocellular carcinoma (HCC) is the most common primary liver malignancy and accounts for about 6% of all new cancers diagnosed worldwide. Moreover, it is the third and the fifth leading cause of death from cancer in men and women, respectively. HBV and HCV chronic infection is the main risk facto...
Autores principales: | Petrizzo, A., Mauriello, A., Tornesello, M. L., Buonaguro, F. M., Tagliamonte, M., Buonaguro, L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5870199/ https://www.ncbi.nlm.nih.gov/pubmed/29599818 http://dx.doi.org/10.1186/s13027-018-0183-8 |
Ejemplares similares
-
Systems Biology Approach for Cancer Vaccine Development and Evaluation
por: Circelli, Luisa, et al.
Publicado: (2015) -
Innate immunity and hepatitis C virus infection: a microarray’s view
por: Buonaguro, Luigi, et al.
Publicado: (2012) -
Prediction of individual immune responsiveness to a candidate vaccine by a systems vaccinology approach
por: Petrizzo, Annacarmen, et al.
Publicado: (2014) -
High Somatic Mutation and Neoantigen Burden Do Not Correlate with Decreased Progression-Free Survival in HCC Patients not Undergoing Immunotherapy
por: Mauriello, Angela, et al.
Publicado: (2019) -
Application of the Immunoscore as prognostic tool for hepatocellular carcinoma
por: Petrizzo, Annacarmen, et al.
Publicado: (2016)